268 related articles for article (PubMed ID: 24764452)
41. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.
Kim M; Allen B; Korhonen EA; Nitschké M; Yang HW; Baluk P; Saharinen P; Alitalo K; Daly C; Thurston G; McDonald DM
J Clin Invest; 2016 Sep; 126(9):3511-25. PubMed ID: 27548529
[TBL] [Abstract][Full Text] [Related]
42. Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner.
Woo KV; Qu X; Babaev VR; Linton MF; Guzman RJ; Fazio S; Baldwin HS
J Clin Invest; 2011 Apr; 121(4):1624-35. PubMed ID: 21383501
[TBL] [Abstract][Full Text] [Related]
43. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells.
Kim KL; Shin IS; Kim JM; Choi JH; Byun J; Jeon ES; Suh W; Kim DK
Cardiovasc Res; 2006 Dec; 72(3):394-402. PubMed ID: 17054925
[TBL] [Abstract][Full Text] [Related]
44. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis.
Puri MC; Bernstein A
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12753-8. PubMed ID: 14530387
[TBL] [Abstract][Full Text] [Related]
45. Ligand-independent Tie2 dimers mediate kinase activity stimulated by high dose angiopoietin-1.
Yamakawa D; Kidoya H; Sakimoto S; Jia W; Naito H; Takakura N
J Biol Chem; 2013 May; 288(18):12469-77. PubMed ID: 23504320
[TBL] [Abstract][Full Text] [Related]
46. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.
Morisada T; Oike Y; Yamada Y; Urano T; Akao M; Kubota Y; Maekawa H; Kimura Y; Ohmura M; Miyamoto T; Nozawa S; Koh GY; Alitalo K; Suda T
Blood; 2005 Jun; 105(12):4649-56. PubMed ID: 15705793
[TBL] [Abstract][Full Text] [Related]
47.
Michelini S; Ricci M; Veselenyiova D; Kenanoglu S; Kurti D; Baglivo M; Fiorentino A; Basha SH; Priya S; Serrani R; Krajcovic J; Dundar M; Dautaj A; Bertelli M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947856
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional and post-translation regulation of the Tie1 receptor by fluid shear stress changes in vascular endothelial cells.
Chen-Konak L; Guetta-Shubin Y; Yahav H; Shay-Salit A; Zilberman M; Binah O; Resnick N
FASEB J; 2003 Nov; 17(14):2121-3. PubMed ID: 14500555
[TBL] [Abstract][Full Text] [Related]
49. Lymphatic collecting vessel maturation and valve morphogenesis.
Vittet D
Microvasc Res; 2014 Nov; 96():31-7. PubMed ID: 25020266
[TBL] [Abstract][Full Text] [Related]
50. Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis.
Thurston G
Cell Tissue Res; 2003 Oct; 314(1):61-8. PubMed ID: 12915980
[TBL] [Abstract][Full Text] [Related]
51. Preclinical validation of a novel metastasis-inhibiting Tie1 function-blocking antibody.
Singhal M; Gengenbacher N; La Porta S; Gehrs S; Shi J; Kamiyama M; Bodenmiller DM; Fischl A; Schieb B; Besemfelder E; Chintharlapalli S; Augustin HG
EMBO Mol Med; 2020 Jun; 12(6):e11164. PubMed ID: 32302470
[TBL] [Abstract][Full Text] [Related]
52. In vitro inhibition of cancer angiogenesis and migration by a nanobody that targets the orphan receptor Tie1.
Meltzer M; Eliash N; Azoulay Z; Hadad U; Papo N
Cell Mol Life Sci; 2022 May; 79(6):312. PubMed ID: 35604495
[TBL] [Abstract][Full Text] [Related]
53. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema.
Brouillard P; Murtomäki A; Leppänen VM; Hyytiäinen M; Mestre S; Potier L; Boon LM; Revencu N; Greene AK; Anisimov A; Salo MH; Hinttala R; Eklund L; Quéré I; Alitalo K; Vikkula M
J Clin Invest; 2024 May; ():. PubMed ID: 38820174
[TBL] [Abstract][Full Text] [Related]
54. The mechanosensory channel PIEZO1 functions upstream of angiopoietin/TIE/FOXO1 signaling in lymphatic development.
Du J; Liu P; Zhou Y; Misener S; Sharma I; Leeaw P; Thomson BR; Jin J; Quaggin SE
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747287
[TBL] [Abstract][Full Text] [Related]
55. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Dezube BJ; Tognazzi K; Dvorak HF; Yancopoulos GD
Am J Pathol; 2000 Jun; 156(6):2179-83. PubMed ID: 10854238
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue.
Shahrara S; Volin MV; Connors MA; Haines GK; Koch AE
Arthritis Res; 2002; 4(3):201-8. PubMed ID: 12010571
[TBL] [Abstract][Full Text] [Related]
57. Modulation of angiopoietin-2 and Tie2: Organ specific effects of microvascular leakage and edema in mice.
van Leeuwen ALI; Dekker NAM; Ibelings R; Tuip-de Boer AM; van Meurs M; Molema G; van den Brom CE
Microvasc Res; 2024 Jul; 154():104694. PubMed ID: 38723844
[TBL] [Abstract][Full Text] [Related]
58. Loss of flow responsive Tie1 results in Impaired
Aortic valve remodeling.
Qu X; Violette K; Sewell-Loftin MK; Soslow J; Saint-Jean L; Hinton RB; Merryman WD; Baldwin HS
Dev Biol; 2019 Nov; 455(1):73-84. PubMed ID: 31319059
[TBL] [Abstract][Full Text] [Related]
59. [Advances of Angiopoietin-Tie axis in vascular and lymphatic system-related diseases].
Wang R; Huang M; Xu Y; Yuan C; Huang M; Jiang L
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2633-2644. PubMed ID: 34472284
[TBL] [Abstract][Full Text] [Related]
60. Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin.
Dalton AC; Shlamkovitch T; Papo N; Barton WA
PLoS One; 2016; 11(10):e0163732. PubMed ID: 27695111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
